Lista de obras - A Longhi - Dominio Público Uruguay

A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients.

artículo científico publicado en 2014

A comment on “Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders” ⬇️

artículo científico publicado el 1 de noviembre de 2003

Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years

artículo científico publicado en 2007

Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy

article

Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution

scientific article published on 05 February 2019

Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients

scientific article published on 01 December 2006

Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results

scientific article published on 08 August 2018

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.

artículo científico publicado en 2017

Ewing sarcoma in patients over 40 years of age: a prospective analysis of 31 patients treated at a single institution

artículo científico publicado en 2016

Ewing's sarcoma family tumors of the humerus: outcome of patients treated with radiotherapy, surgery or surgery and adjuvant radiotherapy

article

Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.

artículo científico publicado en 2017

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

artículo científico publicado en 2016

Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution

artículo científico publicado en 2005

Height as a risk factor for osteosarcoma.

artículo científico publicado en 2005

High grade malignant peripheral nerve sheath tumors: outcome of 62 patients with localized disease and review of the literature.

scientific article published on December 2010

High-Dose Medroxyprogesterone Acetate versus Oophorectomy as First-Line Therapy of Advanced Breast Cancer in Premenopausal Patients ⬇️

artículo científico publicado el 1 de enero de 1991

Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients

scientific article published on 01 June 2006

Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

artículo científico publicado en 2009

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.

artículo científico publicado en 2018

Late relapse in osteosarcoma

artículo científico publicado en 2006

Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution

article

Long-Term Follow-up of a Randomized Study of Oral Etoposide versus Viscum album Fermentatum Pini as Maintenance Therapy in Osteosarcoma Patients in Complete Surgical Remission after Second Relapse

artículo científico publicado en 2020

Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma

article

Maternal and Neonatal Outcomes in Pregnancies Complicated by Bone and Soft-Tissue Tumors

artículo científico publicado en 2005

Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis

artículo científico publicado en 2003

Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor

article

Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999

scientific article published on 01 June 2007

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide

artículo científico publicado en 2003

Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome

artículo científico publicado en 2003

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

artículo científico publicado en 2005

Non-metastatic osteosarcoma of the extremities in children aged 5 years or younger.

artículo científico publicado en 2010

Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy

Osteosarcoma in patients older than 65 years.

artículo científico publicado en 2008

Palliative therapy for osteosarcoma.

artículo científico publicado en 2011

Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999

artículo científico publicado en 2006

Pazopanib in relapsed osteosarcoma patients: report on 15 cases

artículo científico publicado en 2018

Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: safety and efficacy

scientific article published on 16 April 2020

Phase II study of imatinib in advanced chordoma

artículo científico publicado en 2012

Primary high-grade osteosarcoma: comparison between preadolescent and older patients.

artículo científico publicado en 2005

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

artículo científico publicado en 2006

Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.

artículo científico publicado en 2006

Pulmonary nodules in osteosarcoma patients: differential diagnosis of central venous catheter-related infections in the lungs.

artículo científico publicado en 2006

Salivary gland second cancer after bone sarcoma treatment

artículo científico publicado en 2015

Second malignancy in 597 patients with ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999

artículo científico publicado en 2005

Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma.

artículo científico publicado en 2009

Simultaneous osteosarcoma lung metastasis and second primary lung cancer.

artículo científico publicado en 2004

Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma.

artículo científico publicado en 2018

The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma

artículo científico publicado en 2021

The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy

artículo científico publicado en 2006

Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997 ⬇️

artículo científico publicado el 1 de noviembre de 2003

Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy

artículo científico publicado en 2005

Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institution.

artículo científico publicado en 2009

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1.

artículo científico publicado en 2017

Lista de obras de A Longhi

A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients.

A comment on “Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders” ⬇️

Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years

Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy

Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution

Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients

Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.

Ewing sarcoma in patients over 40 years of age: a prospective analysis of 31 patients treated at a single institution

Ewing's sarcoma family tumors of the humerus: outcome of patients treated with radiotherapy, surgery or surgery and adjuvant radiotherapy

Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution

Height as a risk factor for osteosarcoma.

High grade malignant peripheral nerve sheath tumors: outcome of 62 patients with localized disease and review of the literature.

High-Dose Medroxyprogesterone Acetate versus Oophorectomy as First-Line Therapy of Advanced Breast Cancer in Premenopausal Patients ⬇️

Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients

Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.

Late relapse in osteosarcoma

Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution

Long-Term Follow-up of a Randomized Study of Oral Etoposide versus Viscum album Fermentatum Pini as Maintenance Therapy in Osteosarcoma Patients in Complete Surgical Remission after Second Relapse

Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma

Maternal and Neonatal Outcomes in Pregnancies Complicated by Bone and Soft-Tissue Tumors

Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis

Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor

Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide

Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Non-metastatic osteosarcoma of the extremities in children aged 5 years or younger.

Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy

Osteosarcoma in patients older than 65 years.

Palliative therapy for osteosarcoma.

Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999

Pazopanib in relapsed osteosarcoma patients: report on 15 cases

Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: safety and efficacy

Phase II study of imatinib in advanced chordoma

Primary high-grade osteosarcoma: comparison between preadolescent and older patients.

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.

Pulmonary nodules in osteosarcoma patients: differential diagnosis of central venous catheter-related infections in the lungs.

Salivary gland second cancer after bone sarcoma treatment

Second malignancy in 597 patients with ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999

Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma.

Simultaneous osteosarcoma lung metastasis and second primary lung cancer.

Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma.

The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma

The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy

Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997 ⬇️

Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy

Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institution.

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1.

Twenty-year follow-up of osteosarcoma of the extremity treated with adjuvant chemotherapy